ArticleBritish journal of haematology2020
First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia.
Stephen Dong, Tarek Khedro, Pamela Ward, Louis Dubeau, Bassam Yaghmour, Imran Siddiqi, George Yaghmour
Open access · bronzeAbstract readCase ReportsLetter
In one paragraphArticle in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 1 institution in 1 country.
Stephen DongJane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Tarek KhedroJane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Pamela WardDepartment of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Louis DubeauDepartment of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Bassam YaghmourPulmonary, Critical Care, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Imran SiddiqiDepartment of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
George YaghmourJane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-6988-3556 University of Southern California · US
Funding
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4MNCI NIH HHS P30 CA014089
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Mutation, MissenseAmino Acid SubstitutionHumansLeukemia, Prolymphocytic, T-CellMiddle AgedProto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins B-rafBRAF V600E mutationdasatinibT-cell prolymphocytic leukemiavemurafenibvenetoclax (BCL-2 inhibitor)
Identifiers
PMID32712959
PMCPMC9007147
OpenAlexW3045440607
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390